BCL2 and acute myeloid leukemia: Functionally defined LSCs in AML are characterised by low levels of reactive oxygen species (ROS low) and the aberrant expression of BCL2 apoptosis regulator (Bcl-2), which is responsible for the maintenance of OXPHOS [105].